Login / Signup
Yi Wang
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 2
Top Topics
Free Survival
Poor Prognosis
Case Report
Top Venues
Journal of oncology
Evidence-based complementary and alternative medicine : eCAM
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Pengcheng Yu
,
Weiyang He
,
Yanqiang Zhang
,
Xiang-Dong Cheng
,
Yue Wu
,
Yi Wang
,
Zhehan Bao
,
Yuhang Xia
,
Ruolan Zhang
,
Mengxuan Cao
,
Li Yuan
,
Xiang-Dong Cheng
,
Zhiyuan Xu
SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer.
Journal of oncology
2022 (2022)
Zhehan Bao
,
Yanqiang Zhang
,
Pengcheng Yu
,
Yi Wang
,
Xiang-Dong Cheng
,
Yuhang Xia
,
Li Yuan
,
Zhi-Yuan Xu
,
Xiang-Dong Cheng
High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer.
Evidence-based complementary and alternative medicine : eCAM
2022 (2022)